VitaNova Life Sciences Corp (VNOV)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-30. Amounts in USD.

Revenue TTM

-1.5M 0 1.5M 3M 4.5M Q4 '18: 0 Q1 '19: -18.4K Q2 '19: -18.4K Q3 '19: -18.4K Q4 '19: 0 Q1 '20: 0 Q2 '20: 0 Q3 '20: 0 Q4 '20: 0 Q1 '21: 0 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q1 '22: 0 Q2 '22: 45K Q3 '22: 75K Q4 '22: 120K Q1 '23: 135K Q2 '23: 100K Q3 '23: 80K Q4 '23: 38K Q1 '24: 23K Q2 '24: 13K Q3 '24: 29.1K Q4 '24: 570.7K Q1 '25: 679.2K Q2 '25: 971.3K Q3 '25: 1.3M Q4 '25: 2.7M Q1 '26: 2.7M Q2 '26: 2.8M Q3 '26: 3.2M Q4 '26: 3M Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25 Q4 '26

Gross Profit TTM

-700K 0 700K 1.4M 2.1M Q4 '18: 0 Q1 '19: -15.5K Q2 '19: -29.5K Q3 '19: -29.5K Q4 '19: 0 Q4 '24: 377.7K Q1 '25: 450.9K Q2 '25: 606.7K Q3 '25: 769.9K Q4 '25: 1.6M Q1 '26: 1.6M Q2 '26: 1.7M Q3 '26: 1.8M Q4 '26: 910.6K Q1 '19 Q3 '19 Q4 '24 Q2 '25 Q4 '25 Q2 '26 Q4 '26

Operating Income TTM

-500K 0 500K 1M 1.5M Q4 '19: -74.2K Q1 '20: -78.2K Q2 '20: -89.7K Q3 '20: -59.6K Q4 '20: -72.3K Q1 '21: -63.7K Q2 '21: -56.6K Q3 '21: -52.9K Q4 '21: -52.1K Q1 '22: -51.3K Q2 '22: -68.9K Q4 '24: 205.6K Q1 '25: 184.5K Q2 '25: 255.8K Q3 '25: 358.7K Q4 '25: 1.2M Q1 '26: 1.2M Q2 '26: 1.3M Q3 '26: 1.2M Q4 '26: 3.6K Q1 '20 Q4 '20 Q3 '21 Q2 '22 Q2 '25 Q1 '26 Q4 '26

Net Income TTM

-300K 0 300K 600K 900K Q4 '18: -1.6K Q1 '19: -27K Q2 '19: -72.8K Q3 '19: -96.8K Q4 '19: -106.2K Q1 '20: -110.2K Q2 '20: -89.7K Q3 '20: -59.6K Q4 '20: -72.3K Q1 '21: -63.7K Q2 '21: -56.6K Q3 '21: -52.9K Q4 '21: -52.1K Q1 '22: 101.7K Q2 '22: 129.1K Q3 '22: 140.9K Q4 '23: -24.2K Q1 '24: -50.6K Q2 '24: -62K Q3 '24: -31.4K Q4 '24: 140.9K Q1 '25: 109.9K Q2 '25: 151.3K Q3 '25: 218.3K Q4 '25: 850.7K Q1 '26: 859.7K Q2 '26: 862.8K Q3 '26: 745.5K Q4 '26: -37.3K Q4 '18 Q4 '19 Q4 '20 Q4 '21 Q4 '23 Q4 '24 Q4 '25 Q4 '26

Cost of Revenue TTM

0 800K 1.6M 2.4M Q4 '24: 193K Q1 '25: 228.3K Q2 '25: 364.6K Q3 '25: 483.6K Q4 '25: 1.1M Q1 '26: 1.1M Q2 '26: 1.1M Q3 '26: 1.4M Q4 '26: 2.1M Q4 '24 Q2 '25 Q4 '25 Q2 '26 Q4 '26

Operating Cash Flow TTM

-1.2M -800K -400K 0 400K 800K 1.2M Q4 '18: -14.8K Q1 '19: -31.9K Q2 '19: 4.1K Q3 '19: -37.1K Q4 '19: -49.1K Q1 '20: -58.2K Q2 '20: -81.9K Q3 '20: -52.4K Q4 '20: -53.6K Q1 '21: -33.7K Q2 '21: -52.6K Q3 '21: -57.1K Q4 '21: -42.3K Q1 '22: -49.2K Q2 '22: 936 Q3 '22: 17.9K Q4 '22: 4.1K Q1 '23: 17.8K Q2 '23: 3.5K Q3 '23: -29.9K Q4 '23: -18.4K Q1 '24: -51.3K Q2 '24: -64.6K Q3 '24: -187K Q4 '24: -375.9K Q1 '25: -853.7K Q2 '25: -837K Q3 '25: -477.5K Q4 '25: 192.8K Q1 '26: 960.6K Q2 '26: 1.2M Q3 '26: 865.2K Q4 '26: 814.4K Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25 Q4 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 9M 18M 27M Q1 '18: 3.5M Q2 '18: 4.1M Q3 '18: 5.9M Q1 '19: 5.9M Q2 '19: 5.9M Q3 '19: 5.9M Q1 '22: 5.9M Q2 '22: 5.9M Q3 '22: 5.9M Q1 '23: 5.9M Q2 '23: 5.9M Q3 '23: 5.9M Q1 '24: 5.9M Q2 '24: 5.9M Q3 '24: 6.1M Q1 '25: 25M Q2 '25: 25M Q3 '25: 8.3M Q1 '26: 25M Q2 '26: 25M Q3 '26: 8.3M Q3 '18 Q3 '19 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.01 0.00 0.01 0.03 0.04 Q4 '18: 0.00 Q1 '19: 0.00 Q4 '20: 0.00 Q1 '21: 0.00 Q2 '21: 0.00 Q3 '21: 0.00 Q4 '21: -0.01 Q1 '22: 0.01 Q2 '22: 0.01 Q3 '22: 0.01 Q4 '22: 0.02 Q1 '23: 0.00 Q2 '23: 0.00 Q3 '23: 0.00 Q4 '23: 0.00 Q1 '24: 0.00 Q2 '24: 0.00 Q3 '24: 0.00 Q4 '24: 0.01 Q1 '25: 0.01 Q2 '25: 0.01 Q3 '25: 0.02 Q4 '25: 0.03 Q1 '26: 0.03 Q2 '26: 0.03 Q3 '26: 0.01 Q4 '26: -0.00 Q4 '20 Q4 '21 Q4 '22 Q4 '23 Q4 '24 Q4 '25 Q4 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.